Challenging Market Despite Government's Increasing Spending

BMI View: We believe that despite the government's recent efforts to extend healthcare coverage and improve competitiveness in Mexico's pharmaceutical sector, persistent shortcomings in the allocation of healthcare funds at state level mean the country will continue to trail behind Latin America's largest economies in terms of attractiveness to pharmaceuticals and medical device suppliers.

To read the full article, please choose one of the following options: